Opacifying preparations for Xray examinations; diagnostic reagents designed to be administered to the patient
HS Code: 3006300000
SECTION 6
PRODUCTS OF THE CHEMICAL OF ALLIED INDUSTRIES
CHAPTER 30
Pharmaceutical products
HEADING 3006
Pharmaceutical goods specified in Note 4 to this Chapter;
HS Code Structure Breakdown
| Level | Code | Description |
|---|---|---|
| Section | 6 | PRODUCTS OF THE CHEMICAL OF ALLIED INDUSTRIES |
| Chapter | 30 | Pharmaceutical products |
| Heading | 3006 | Pharmaceutical goods specified in Note 4 to this Chapter; |
| Subheading | 300630 | Opacifying preparations for Xray examinations; diagnostic reagents designed to be administered to the patient |
| Commodity | 3006300000 | Opacifying preparations for Xray examinations; diagnostic reagents designed to be administered to the patient |
HS Code 3006300000 for Opacifying preparations for Xray examinations; diagnostic reagents designed to be administered to the patient
Product Wiki
Opacifying preparations for Xray examinations; diagnostic reagents designed to be administered to the patient has a clear classification code under the Harmonized Commodity Description and Coding System (HS Code), serving as an essential basis for customs authorities worldwide to conduct trade statistics and levy tariffs.
Cross-border trade data shows that China holds a non-negligible market share in the manufacturing and export supply of Opacifying preparations for Xray examinations; diagnostic reagents designed to be administered to the patient, with its export volume maintaining a high level over the long term.
Governments and industry associations worldwide usually set different market access standards, quality certifications, and environmental requirements for the import and export of Opacifying preparations for Xray examinations; diagnostic reagents designed to be administered to the patient.
With technological advancements and the diversification of market demands, the scope of application for Opacifying preparations for Xray examinations; diagnostic reagents designed to be administered to the patient continues to expand, driving the development of related industries.
Currently, the global supply-demand balance of Opacifying preparations for Xray examinations; diagnostic reagents designed to be administered to the patient is profoundly affected by macroeconomic fluctuations and geopolitics, with market prices and trade flows exhibiting cyclical variations.
Partner



Our licenses

China

HK MSO License

Singapore

UK API License

Netherlands

US MSB

CA MSB

AU RSP

